Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Mylan Inc    

MYLAN INC
Mes dernières consult.
Most popular
  Report  
 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials (USD)
Sales 2018 12 320 M
EBIT 2018 3 791 M
Net income 2018 1 351 M
Debt 2018 13 214 M
Yield 2018 -
Sales 2019 12 925 M
EBIT 2019 3 947 M
Net income 2019 1 630 M
Debt 2019 10 882 M
Yield 2019 -
P/E ratio 2018 12,92
P/E ratio 2019 10,65
EV / Sales2018 2,72x
EV / Sales2019 2,41x
Capitalization 20 297 M
More Financials
Company
Mylan N.V., is a pharmaceutical company which engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products.The company was founded on July 7, 2014 and is headquartered in Hatfield, United Kingdom. 
Sector
Pharmaceuticals
Calendar
06/29Shareholder meeting
More about the company
Surperformance© ratings of Mylan Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on MYLAN INC
05/24MYLAN NV : Free Daily Technical Summary Reports on Mylan and Three Other Generic..
AC
05/18GSK bets on lift from new lung drugs ahead of Advair's last gasp
RE
05/16Evolus investors frown as FDA declines to approve Botox rival
RE
05/14MYLAN : and West Virginia University Join Forces to Inspire West Virginia Youth ..
PR
05/10In Europe, Mylan's rivals try to plug EpiPen shortages
RE
05/09MYLAN : May Be Gem in Rough Generic Sector
DJ
05/09MYLAN : Statement on Supply of EpiPen® (epinephrine injection, USP) Auto-Injecto..
PU
05/09MYLAN : Reports First Quarter 2018 Results and Reaffirms 2018 Guidance
PR
05/02MYLAN : to Release First Quarter 2018 Financial Results on May 9, 2018
PR
04/25Currency and pricing squeeze GSK as new shingles vaccine shines
RE
More news
Sector news : Pharmaceuticals - NEC
05/25GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
05/25LIVESTOCK HIGHLIGHTS : Top Stories of the Day
DJ
05/25ADRs End Lower; Major Oil Companies, Acorn International, and AstraZeneca Tra..
DJ
05/25Bayer cuts Monsanto synergy target by $300 million due to divestments
RE
05/25LONDON STOCK EXCHANGE : Oil weighs on FTSE, Kingfisher shines
RE
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015Mylan (MYL) Heather M. Bresch on Q4 2014 Results - Earnings Call Transcript 
2015Mylan Q4 revenues up 15%, Specialty up 38% 
2015Mylan (MYL) Q4 2014 Results - Earnings Call Webcast 
2015Mylan EPS in-line, beats on revenue 
2015Notable earnings after Monday?s close 
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 49,7 $
Spread / Average Target 26%
EPS Revisions
Managers
NameTitle
Heather M. Bresch Chief Executive Officer & Director
Rajiv Malik President & Director
Robert J. Coury Executive Chairman
Kenneth Scott Parks Chief Financial Officer
Wendy Cameron Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
MYLAN INC20 297
JOHNSON & JOHNSON-11.45%325 801
PFIZER-0.91%208 713
NOVARTIS-8.30%194 397
ROCHE HOLDING LTD.-9.17%189 708
MERCK AND COMPANY5.01%158 970